Eurofins Acquires Dermscan Group, Strengthens Expertise in Cosmetic Testing

Eurofins has announced the acquisition of Dermscan Group, a well-recognized testing company with a global laboratory network.

Excellence in Safety & Efficacy

During 28 years, Dermscan has built a significant reputation for excellence in safety, efficacy, clinical studies and in-vitro testing, serving the cosmetics, personal care, and pharmaceutical industries.

Eurofins is excited to strengthen its expertise in cosmetic testing in a market where the desire for safety and efficacy is among the highest in the world.

Dermscan brings to Eurofins Cosmetics innovative capabilities as well as strong competences from its worldwide expert team (France, Poland, Tunisia, Thailand and Mauritius).

In line with Eurofins Cosmetics’ strategy to expand its leading global cosmetic testing footprint, this acquisition reinforces the position of Eurofins Cosmetics, with now on 40 state-of-the-art laboratories active in that field, across Europe, North America, Asia, Australia and Africa, offering an unmatched range of clinical, sensory, chemical, in-vitro and microbiological testing services to its clients.

Expanding in Cosmetic Testing Industry

Stéphane Barrau, VP Eurofins Consumer Product Testing, said:

“We are confident that this acquisition will contribute to the expansion of our expertise and footprint in the cosmetics testing industry by offering an increasingly wider scope of top-class services and facilitating the development of innovative new solutions for our customers”

Frédérique Girard-Ory, General Manager of Dermscan, said:

“This is a new adventure and a new challenge for the entire Dermscan’s team that we are very excited to undertake. Joining Eurofins will enable us to propose an even more complete and diversified offer to the cosmetics industry.”